Dividends Calendar Earnings Calendar
NTLA

NTLA | Intellia Therapeutics Inc

Intellia Therapeutics Inc
Category: Biotechnology company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Cambridge, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 3.76B
  • Prev closed: 13.36
  • Open: 13.87
  • High: 13.91
  • Low: 13.37
  • 52 week low: 9.18
  • 52 week high: 19
  • Dividends:No Dividends

Next ER: May 5, 2022  Before Market Opens



Top Stories (NTLA)

    About the Company

    Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 4, 2022
    May 5, 2022-1.96 / -1.1311.25M / 8.7MBeat!
    February 24, 2022-1.09 / -0.94912.85M / 8.26MBeat!
    November 4, 2021-0.97 / -0.84717.2M / 8.66M
    August 5, 2021-1.01 / -0.63426.55M / 12.21M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 5, 2022 50.03 52.22
    54.80
    48.73
    1.56M -10.18%
    May 4, 2022 55.70 51.85
    56.73
    49.38
    1.61M 7.57%
    May 3, 2022 51.78 51.58
    53.82
    50.37
    746.90K 0.33%
    May 2, 2022 51.61 48.00
    51.83
    47.08
    1.20M 5.26%
    Apr 29, 2022 49.03 49.69
    52.57
    48.90
    864.71K -2.51%
    Apr 28, 2022 50.29 50.41
    51.84
    47.02
    1.08M 1.93%
    Apr 27, 2022 49.34 49.62
    51.34
    48.07
    892.76K -1.02%
    Apr 26, 2022 49.85 52.79
    54.12
    49.75
    898.98K -6.98%
    Apr 25, 2022 53.59 50.35
    54.00
    50.35
    984.88K 5.78%
    Apr 22, 2022 50.66 50.93
    52.89
    50.20
    781.96K 0.30%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:104

    News

    News for (NTLA)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Nessan Bermingham, PhD
    • General Counsel :  José Rivera

    Talk about Intellia Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 5, 2022 (Same day)

    hain shop cx syna sq gpro clls w z k lamr d 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 73
    HOLD 27
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedInInstagram

    Peers / Similar stocks 

    xlv 

    Other stocks 

    ibm tgt aap sig pdco azo tvpt low afsi amg cgc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet